ES2123005T3 - Composicion farmaceutica que contiene carbacol y otras sustancias colinergicas. - Google Patents

Composicion farmaceutica que contiene carbacol y otras sustancias colinergicas.

Info

Publication number
ES2123005T3
ES2123005T3 ES92918041T ES92918041T ES2123005T3 ES 2123005 T3 ES2123005 T3 ES 2123005T3 ES 92918041 T ES92918041 T ES 92918041T ES 92918041 T ES92918041 T ES 92918041T ES 2123005 T3 ES2123005 T3 ES 2123005T3
Authority
ES
Spain
Prior art keywords
carbacol
pharmaceutical composition
composition containing
cholinergic
cholinergic substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92918041T
Other languages
English (en)
Inventor
Rudolph Wolfgang Hahnenberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Application granted granted Critical
Publication of ES2123005T3 publication Critical patent/ES2123005T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)

Abstract

EL PRESENTE INVENTO SE REFIERE AL EMPLEO DE SUBSTANCIAS BASADAS EN CARBAZOL, METACOLINA, BETANECOL, FURTRETONIO Y ARECOLINA QUE TIENEN PROPIEDADES COLINERGICAS PARA LA PREPARACION DE MEDICAMENTOS PARA TRATAMIENTO DE QUERATOCONJUNTIVITIS SECA.
ES92918041T 1991-08-13 1992-08-07 Composicion farmaceutica que contiene carbacol y otras sustancias colinergicas. Expired - Lifetime ES2123005T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9102340A SE9102340D0 (sv) 1991-08-13 1991-08-13 Pharmaceutical composition containing carbachol and othercholinergic substances

Publications (1)

Publication Number Publication Date
ES2123005T3 true ES2123005T3 (es) 1999-01-01

Family

ID=20383456

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92918041T Expired - Lifetime ES2123005T3 (es) 1991-08-13 1992-08-07 Composicion farmaceutica que contiene carbacol y otras sustancias colinergicas.

Country Status (14)

Country Link
US (1) US5679713A (es)
EP (2) EP0528776A1 (es)
JP (1) JPH06509801A (es)
AT (1) ATE172114T1 (es)
AU (1) AU671805B2 (es)
CA (1) CA2114239C (es)
DE (1) DE69227324T2 (es)
DK (1) DK0661968T3 (es)
ES (1) ES2123005T3 (es)
FI (1) FI108516B (es)
HU (1) HU221592B (es)
NO (1) NO306447B1 (es)
SE (1) SE9102340D0 (es)
WO (1) WO1993003718A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1250927A3 (en) * 1997-02-24 2003-03-26 S.L.A. Pharma AG Pharmaceutical composition for topical application comprising nifedipine
JP2001513495A (ja) * 1997-08-08 2001-09-04 デューク ユニバーシティ 外科的処置を容易にする組成物、装置および方法
US6711436B1 (en) 1997-08-08 2004-03-23 Duke University Compositions, apparatus and methods for facilitating surgical procedures
US6395758B1 (en) * 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US7220422B2 (en) * 2003-05-20 2007-05-22 Allergan, Inc. Methods and compositions for treating eye disorders
US8299079B2 (en) 2009-05-22 2012-10-30 Kaufman Herbert E Preparations and methods for ameliorating or reducing presbyopia
DK2498771T3 (da) 2009-11-12 2014-01-27 Acacia Pharma Ltd Anvendelse af bethanechol til behandling af xerostomi
AR104177A1 (es) * 2015-04-03 2017-07-05 Santen Pharmaceutical Co Ltd Sistema para la administración de fármacos en la glándula lagrimal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2185220A (en) * 1938-08-17 1940-01-02 Smith Kline French Lab Medicinal agent
GB1386864A (en) * 1972-02-11 1975-03-12 Avicon Inc Micro-crystalline collage-containing pharmaceutical compositions useful for topical applications
US4804539A (en) * 1986-07-28 1989-02-14 Liposome Technology, Inc. Ophthalmic liposomes
JPH02500360A (ja) * 1986-07-28 1990-02-08 リポソーム　テクノロジー，インコーポレイテッド 粘膜組織上での高い保持力を有するリポソーム

Also Published As

Publication number Publication date
FI940637A (fi) 1994-02-11
US5679713A (en) 1997-10-21
EP0661968A1 (en) 1995-07-12
EP0661968B1 (en) 1998-10-14
DE69227324T2 (de) 1999-04-29
HU221592B (hu) 2002-11-28
CA2114239A1 (en) 1993-02-14
ATE172114T1 (de) 1998-10-15
JPH06509801A (ja) 1994-11-02
AU2463192A (en) 1993-03-16
NO306447B1 (no) 1999-11-08
AU671805B2 (en) 1996-09-12
SE9102340D0 (sv) 1991-08-13
HUT65946A (en) 1994-08-29
DE69227324D1 (de) 1998-11-19
EP0528776A1 (en) 1993-02-24
HU9400405D0 (en) 1994-05-30
FI108516B (fi) 2002-02-15
CA2114239C (en) 2003-10-21
NO940400L (no) 1994-02-07
DK0661968T3 (da) 1999-06-23
NO940400D0 (no) 1994-02-07
FI940637A0 (fi) 1994-02-11
WO1993003718A1 (en) 1993-03-04

Similar Documents

Publication Publication Date Title
PT100963A (pt) Composicoes farmaceuticas para aplicacao topica de elevada penetracao atraves da pele que compreendem certos polimeros nao-ionicos especificos
RU94040855A (ru) Фармацевтическая композиция на основе эмульсии масло в воде для местного применения, содержащая ароматическое активное вещество
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
ATE184598T1 (de) Enniatine und enniatinderivate zur bekämpfung von endoparasiten
ATE203019T1 (de) Neue (r)-5-carbamoyl-8-fluor-3-n,n- disubstituierte-amino-3,4-dihydro-2h-1- benzopyrane
RU94043772A (ru) Пропинил-диароматические соединения, фармацевтические и косметические составы на их основе
DE69531098D1 (de) Piperidine und pyrrolidine
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
DK1167354T3 (da) Racemisk huperzin A
ES2123005T3 (es) Composicion farmaceutica que contiene carbacol y otras sustancias colinergicas.
BR9908427A (pt) Composições farmacêuticas e uso das mesmas
SE8600658D0 (sv) Novel composition of matter
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
MX9203374A (es) Composicion farmaceutica que contiene l-alfa-glicerofosforilcolina.
DK116386D0 (da) Polyprenylforbindelser, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
MX9203732A (es) R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos.
MY115795A (en) Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
DE68901656D1 (de) Pharmazeutische zusammensetzung zur milderung der nebenwirkungen von platinhaltigen arzneimitteln.
MX9302986A (es) Medicamento que contiene metrifonato y procedimiento para su preparacion
MX9203900A (es) Composicion farmaceutica que comprende derivados de acido benzimidazolin-2-oxo-1-carboxilico.
BR9813098A (pt) Uso de glicosaminoglicans, preparação farmacêutica, e, combinaçào
BR9106596A (pt) Processo para o tratamento ou profilaxia de uma infeccao associada com retrovirus,uso,composicao farmaceutica para o tratamento ou profilaxia de uma infeccao associada com retrovirus,e,composto
IL89015A (en) Pharmaceutical compositions containing tetrahydropyridine derivatives, certain such novel compounds and their preparation
SE9203296D0 (sv) The use of inositoltrisphate for the preparing of medicaments
AR006437A1 (es) Uso de monohidrocloruro de n-(endo-9-metil-9-azabiciclo [3.3.1]non-3-il)-1- metilimidazol-3-carboxamida, para la fabricacion de un medicamento para eltratamiento o la profilaxis de diarrea y una composicion farmaceutica que lo contiene

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 661968

Country of ref document: ES